Oncogenes and Tumor Suppressor Genes Overview
- Oncogenes are genes that have the potential to cause cancer.
- Tumor suppressor genes are responsible for regulating cell growth and suppressing tumor formation.
Historical Context by Peyton Rous
- In 1909, Francis Peyton Rous discovered a tumor in chickens, leading to Nobel Prize recognition in 1966.
- Observed that a cell-free filtrate from the tumor could induce tumors in other chickens, suggesting a transmissible agent.
Discovery of Rous Sarcoma Virus (RSV)
- Identified as an RNA retrovirus responsible for tumor induction.
- Derived from Avian Leukosis Virus (ALV) when it acquired a cancer-causing gene named v-src.
- Mutant RSV strains lacking functional v-src do not cause cancer.
Proto-oncogenes
- The cellular counterpart of v-src is c-src, a proto-oncogene found in normal chicken cells.
- Proto-oncogenes are crucial the organisms and tend to be highly conserved across species.
Mechanism of Oncogenesis
- Oncogenes can cause phenotypic changes characteristic of cancer; consequently, a single oncogene can trigger transformation.
- Examples of cancer-causing viruses are identified, carrying oncogenes from the host.
Retroviruses and Cancer Induction
- "Acutely transforming" retroviruses can induce cancer quickly (days to weeks).
- "Slowly transforming" retroviruses (e.g., ALV) manipulate the host genome over a longer time via insertional mutagenesis.
- Example: In avian leukemias, ALV inserts into the c-myc proto-oncogene, causing excessive expression and leukemia.
Viral Theory of Human Carcinogenesis
- By 1970, it was hypothesized that many human cancers might stem from viral infections.
- Evidence showed otherwise: cancers do not appear in contagious patterns nor can many cancer-causing viruses be isolated from human cancers (exceptions: HPV, HBV).
Non-viral Oncogenes
- Studies confirmed that non-viral carcinogens could induce proto-oncogenes to become oncogenes.
- Oncogene Transformation Experiments:
- 1979: Chemically altered mouse cells exhibited potential to transform non-malignant cells into malignant ones.
- 1981: Human bladder tumor DNA was also shown to transform mouse fibroblasts into cancerous cells.
Cross-Species Oncogenes
- Observations indicate that oncogenes may act similarly across species, affecting both human and animal cancers.
- Identified animal retroviral oncogenes were homologous with transforming human oncogenes.
Myc Proto-oncogene Amplifications and Translocations
- The Myc proto-oncogene is implicated in various cancers.
- Amplification seen in neuroblastoma, and translocation in Burkitt lymphoma, where the MYC gene is paired with the immunoglobulin gene, activating its transcription.
Tumor Suppressor Genes
- These genes may prevent tumor formation and are critical in the genetic explanation of cancer.
- Cell fusion experiments suggest a recessive nature of cancer in some cases.
- Retinoblastoma serves as a model showing that one allele mutation could be inherited and another acquired, leading to cancer.
Knudson's Two-Hit Hypothesis
- The genetic model posits that one germline mutation plus one somatic mutation results in cancer, particularly in retinoblastoma.
- Challenges include understanding the low likelihood of random second hits causing malignancy.
Loss of Heterozygosity (LOH)
- Contributes to tumor development when both alleles of tumor suppressor genes lose function, often through recombination during mitosis.
Known Tumor Suppressor Genes and Their Functions
- p53: Responds to cellular stress, promotes DNA repair.
- Rb: Regulates cell cycle.
- PTEN: Opposes growth signaling.
- BRCA1/2: Involved in DNA repair, mutation might elevate cancer risks.
Conclusions
- Loss of tumor suppressor genes can increase cellular susceptibility to cancer by allowing oncogenic processes to proceed.
- The second allele's loss (through various mechanisms) can lead to tumorigenesis.
- Future discussions will explore more about tumor suppressor genes' functions further, confirming their paramount role in cell regulation and cancer prevention.